Zotarolimus

Overview

Zotarolimus (ABT-578) is a derivative of Rapamycin ( HY-10219 ), with anti-proliferative activity. Zotarolimus is an immunosuppressant. Zotarolimus is developed specifically for local delivery from stents for the prevention of coronary artery restenosis.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-12424
• CAS No.: 221877-54-9
• Molecular Formula: C52H79N5O12
• Molecular Weight: 966.21
• Purity: 98.0%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.5 mg/mL (2.59 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source